Raleigh Capital Management’s Aurora Cannabis ACB Stock Holding History

Raleigh Capital Management’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8	Closed	–	–	602
2022 Q1	$0	Buy	+8	New	+$339	﹤0.01%	594

Other funds holding ACB

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Raleigh Capital Management's ACB Position: Q2 2022 in Review

Raleigh Capital Management sold out of Aurora Cannabis (ACB) in Q2 2022, closing a stake of 8 shares.

Raleigh Capital Management first reported a position in ACB in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 257 funds tracked by Wall St. Rank hold ACB as of Q2 2022.

Raleigh Capital Management reported no remaining Aurora Cannabis position as of Q2 2022 after selling out during the quarter.
Raleigh Capital Management sold 8 Aurora Cannabis shares in Q2 2022.
Raleigh Capital Management first reported a position in Aurora Cannabis in Q1 2022 and held it in 1 quarter.
Raleigh Capital Management's Aurora Cannabis position peaked at $0 in Q1 2022.
257 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2022.

Based on Raleigh Capital Management's 13F filing for Q2 2022, filed 30 Aug 2022.